NCT03209882

Brief Summary

This study evaluates the effects of transcranial infrared laser stimulation (TILS) on prefrontal metabolism and hemodynamics in veterans with post-traumatic stress disorder (PTSD). The subjects will receive six TILS interventions and one sham intervention in a course of seven weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2019

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

June 14, 2021

Completed
Last Updated

July 23, 2021

Status Verified

June 1, 2021

Enrollment Period

2 years

First QC Date

June 30, 2017

Results QC Date

March 29, 2021

Last Update Submit

June 30, 2021

Conditions

Keywords

Transcranial infrared laser stimulation (TILS)Near-infrared spectroscopy (NIRS)

Outcome Measures

Primary Outcomes (2)

  • Cerebral CCO Changes in Response to TILS and Sham

    Cerebral CCO changes measured by broadband NIRS during six TILS interventions and one sham session.

    7 weeks

  • Cerebral Hemodynamic Changes in Response to TILS and Sham

    Cerebral hemodynamic changes measured by broadband NIRS during every TILS or sham session

    7 weeks

Secondary Outcomes (2)

  • Short-term Memory Scores

    8 weeks

  • Prefrontal Activations in Short-term Memory Processing

    8 weeks

Study Arms (2)

One TILS, one sham, and then five TILS interventions

EXPERIMENTAL

Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.

Device: TILSDevice: sham

One sham, then six TILS interventions

EXPERIMENTAL

Participants first received a sham session, followed by six weekly TILS sessions.

Device: TILSDevice: sham

Interventions

TILSDEVICE

Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.

Also known as: Low-level laser therapy (LLLT)
One TILS, one sham, and then five TILS interventionsOne sham, then six TILS interventions
shamDEVICE

The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.

One TILS, one sham, and then five TILS interventionsOne sham, then six TILS interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • War-zone and non-war-zone veterans
  • Ages 18-60 years old
  • Males and females
  • Able to read, speak, and understand English
  • Medical records showing prior diagnosis of PTSD (here it refers to the records prior to TILS, which will be assessed and obtained in Visit 1)
  • Medical records showing diagnosis of PTSD (here it refers to the CAPS-5 record prior to TILS, which will be assessed and obtained in Visit 1)
  • On stable doses of any psychotropic medications for at least 4 weeks

You may not qualify if:

  • Significant physical disability to perform a computerized memory task
  • Past/current significant medical/neurological/mental health disorders known to affect cognitive functioning (e.g., stroke, dementia, schizophrenia, AIDS)
  • Presence of moderate/severe TBI, defined as having: alteration of consciousness/mental state \>24 hours; posttraumatic amnesia \>1 day; loss of consciousness \>30 minutes; and/or abnormal structural neuroimaging. We will not exclude veterans with mild TBI, which is found in nearly 50% of veterans with PTSD
  • Alcohol abuse/dependence for the past 12- months, as determined by the Rapid Alcohol Problems Screen score \>0
  • Drug abuse/dependence for the past 12- months, as determined by the Drug Abuse Screening Test-10 score \>2
  • Severe depression (PHQ-9 total score \>19), significant risk of suicide (SBQ-R \>6), severe headache (PHQ-15, Item e =2), and/or severe dizziness (PHQ-15, Item g =2)
  • Opiate use in the month prior to study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Engineering Research Building (ERB), University of Texas Arlington

Arlington, Texas, 76010, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Results Point of Contact

Title
Fenghua Tian
Organization
University of Texas at Arlington

Study Officials

  • Fenghua Tian, PhD

    University of Texas at Arlington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Research

Study Record Dates

First Submitted

June 30, 2017

First Posted

July 6, 2017

Study Start

October 1, 2017

Primary Completion

October 8, 2019

Study Completion

October 8, 2019

Last Updated

July 23, 2021

Results First Posted

June 14, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

Phenotypic data collected from the subjects and secondary analysis of data (if any) will be deposited at the National Database for Clinical Trials related to Mental Illness (NDCT; http://ndct.nimh.nih.gov/). It will include data collected from the subjects' forehead with optical neuroimaging modalities as well as the subjects' performance scores in three short-term memory tasks. Additional data documentation and de-identified data will be deposited for sharing along with phenotypic data, which includes demographics and PTSD scores.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Six months after completion of the project
Access Criteria
Investigators working under an institution with a Federal Wide Assurance (FWA) and could be used for secondary study purposes in PTSD diagnosis and therapy.

Locations